ZAI LAB (09688) issued 2 million shares under the stock incentive plan.
Sinopharm Group Co., Ltd. (09688) announced on November 19, 2025 that the company will issue 2 million new shares...
ZAI LAB (09688) announced on November 19, 2025 that the company issued 2 million new shares held by a trustee to fulfill the terms (1) of equity rewards granted under the 2017, 2022, and 2024 equity incentive plans, and (2) as applicable, to exercise options granted under the 2015, 2017, 2022, and 2024 equity incentive plans.
Related Articles
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.
New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.
Hunan Silver (002716.SZ) director Rongqi resigns
Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.
New stock news | Luku Technology submits application to the Hong Kong Stock Exchange, the shipment volume of vein smart locks in 2024 ranks first in the world.
Hunan Silver (002716.SZ) director Rongqi resigns
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
